Genetic variation determines mast cell functions in experimental asthma

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7225-7231

  Becker, Marc ^a   Reuter, Sebastian ^a   Friedrich, Pamela ^a   Doener, Fatma ^a   Michel, Anastasija ^a   Bopp, Tobias ^a   Klein, Matthias ^a   Schmitt, Edgar ^a   Schild, Hansjörg ^a   Radsak, Markus P ^a   Echtenacher, Bernd ^b   Taube, Christian ^a   Stassen, Michael ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL FUNCTION; CONTROLLED STUDY; DISEASE COURSE; GENE MUTATION; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HYPERSENSITIVITY; MAST CELL; MOUSE; MUCUS SECRETION; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CELL COUNT; INFLAMMATION; MAST CELLS; MICE; MICE, CONGENIC; POLYMORPHISM, GENETIC; TH2 CELLS;

EID: 79959534251     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100676     Document Type: Article

References (46)

1. Heib, V., M. Becker, C. Taube, and M. Stassen. 2008. Advances in the understanding of mast cell function. Br. J. Haematol. 142: 683-694.
2. Geissler, E. N., M. A. Ryan, and D. E. Housman. 1988. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55: 185-192.
3. Hayashi, S., T. Kunisada, M. Ogawa, K. Yamaguchi, and S. Nishikawa. 1991. Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. Nucleic Acids Res. 19: 1267-1271.
4. Nocka, K., J. C. Tan, E. Chiu, T. Y. Chu, P. Ray, P. Traktman, and P. Besmer. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9: 1805-1813.
5. Galli, S. J., and Y. Kitamura. 1987. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol. 127: 191-198.
6. Wolters, P. J., J. Mallen-St Clair, C. C. Lewis, S. A. Villalta, P. Baluk, D. J. Erle, and G. H. Caughey. 2005. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient KitW-sh/KitW-sh sash mice. Clin. Exp. Allergy 35: 82-88.
7. Lyon, M. F., and P. H. Glenister. 1982. A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice. Genet. Res. 39: 315-322.
8. Duttlinger, R., K. Manova, G. Berrozpe, T. Y. Chu, V. DeLeon, I. Timokhina, R. S. Chaganti, A. D. Zelenetz, R. F. Bachvarova, and P. Besmer. 1995. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Proc. Natl. Acad. Sci. USA 92: 3754-3758.
9. Duttlinger, R., K. Manova, T. Y. Chu, C. Gyssler, A. D. Zelenetz, R. F. Bachvarova, and P. Besmer. 1993. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118: 705-717. (Pubitemid 23232779)
10. Berrozpe, G., I. Timokhina, S. Yukl, Y. Tajima, M. Ono, A. D. Zelenetz, and P. Besmer. 1999. The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood 94: 2658-2666. (Pubitemid 29477294)
11. Berrozpe, G., V. Agosti, C. Tucker, C. Blanpain, K. Manova, and P. Besmer. 2006. A distant upstream locus control region is critical for expression of the Kit receptor gene in mast cells. Mol. Cell. Biol. 26: 5850-5860.
12. Grimbaldeston, M. A., C.-C. Chen, A. M. Piliponsky, M. Tsai, S.-Y. Tam, and S. J. Galli. 2005. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167: 835-848.
13. Becker, M., V. Heib, M. Klein, F. Doener, T. Bopp, C. Taube, M. Radsak, H. Schild, E. Schmitt, and M. Stassen. 2009. Impaired mast cell-driven immune responses in mice lacking the transcription factor NFATc2. J. Immunol. 182: 6136-6142.
14. Heib, V., M. Becker, T. Warger, G. Rechtsteiner, C. Tertilt, M. Klein, T. Bopp, C. Taube, H. Schild, E. Schmitt, and M. Stassen. 2007. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 110: 946-953. (Pubitemid 47267433)
15. Reuter, S., N. Dehzad, H. Martin, A. Heinz, T. Castor, S. Sudowe, A. B. Reske-Kunz, M. Stassen, R. Buhl, and C. Taube. 2010. Mast cells induce migration of dendritic cells in a murine model of acute allergic airway disease. Int. Arch. Allergy Immunol. 151: 214-222.
16. Nakae, S., L. H. Ho, M. Yu, R. Monteforte, M. Iikura, H. Suto, and S. J. Galli. 2007. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120: 48-55.
17. Reuter, S., A. Heinz, M. Sieren, R. Wiewrodt, E. W. Gelfand, M. Stassen, R. Buhl, and C. Taube. 2008. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur. Respir. J. 31: 773-782.
18. Nigrovic, P. A., D. H. D. Gray, T. Jones, J. Hallgren, F. C. Kuo, B. Chaletzky, M. Gurish, D. Mathis, C. Benoist, and D. M. Lee. 2008. Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am. J. Pathol. 173: 1693-1701.
19. Williams, C. M., and S. J. Galli. 2000. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192: 455-462.
20. Green, R. H., C. E. Brightling, and P. Bradding. 2007. The reclassification of asthma based on subphenotypes. Curr. Opin. Allergy Clin. Immunol. 7: 43-50.
21. Lemanske, R. F., Jr., and W. W. Busse. 2010. Asthma: clinical expression and molecular mechanisms. J. Allergy Clin. Immunol. 125(Suppl 2): S95-S102.
22. Shin, Y. S., K. Takeda, and E. W. Gelfand. 2009. Understanding asthma using animal models. Allergy Asthma Immunol. Res. 1: 10-18.
23. Boyce, J. A., and K. F. Austen. 2005. No audible wheezing: nuggets and conundrums from mouse asthma models. J. Exp. Med. 201: 1869-1873.
24. Nigo, Y. I., M. Yamashita, K. Hirahara, R. Shinnakasu, M. Inami, M. Kimura, A. Hasegawa, Y. Kohno, and T. Nakayama. 2006. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc. Natl. Acad. Sci. USA 103: 2286-2291.
25. Taube, C., X. Wei, C. H. Swasey, A. Joetham, S. Zarini, T. Lively, K. Takeda, J. Loader, N. Miyahara, T. Kodama, et al. 2004. Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J. Immunol. 172: 6398-6406. (Pubitemid 38621249)
26. Yu, M., M. Tsai, S. Y. Tam, C. Jones, J. Zehnder, and S. J. Galli. 2006. Mast cells can promote the development of multiple features of chronic asthma in mice. J. Clin. Invest. 116: 1633-1641.
27. Bradding, P., A. F. Walls, and S. T. Holgate. 2006. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117: 1277-1284.
28. Bradding, P. 2007. Mast cell regulation of airway smooth muscle function in asthma. Eur. Respir. J. 29: 827-830.
29. van der Wouden, J. C., J. H. Uijen, R. M. Bernsen, M. J. Tasche, J. C. de Jongste, and F. Ducharme. 2008. Inhaled sodium cromoglycate for asthma in children. Cochrane Database Syst. Rev. 4: CD002173.
30. Guevara, J. P., F. M. Ducharme, R. Keren, S. Nihtianova, and J. Zorc. 2006. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. Cochrane Database Syst. Rev. 2: CD003558.
31. Djukanović, R., S. J. Wilson, M. Kraft, N. N. Jarjour, M. Steel, K. F. Chung, W. Bao, A. Fowler-Taylor, J. Matthews, W. W. Busse, et al. 2004. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am. J. Respir. Crit. Care Med. 170: 583-593.
32. Bousquet, J., P. Cabrera, N. Berkman, R. Buhl, S. Holgate, S. Wenzel, H. Fox, S. Hedgecock, M. Blogg, and G. D. Cioppa. 2005. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 60: 302-308.
33. Whitehead, G. S., J. K. Walker, K. G. Berman, W. M. Foster, and D. A. Schwartz. 2003. Allergen-induced airway disease is mouse strain dependent. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L32-L42.
34. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
35. Brewer, J. P., A. B. Kisselgof, and T. R. Martin. 1999. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am. J. Respir. Crit. Care Med. 160: 1150-1156.
36. Morokata, T., J. Ishikawa, K. Ida, and T. Yamada. 1999. C57BL/6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses. Immunology 98: 345-351. (Pubitemid 29526955)
37. Takeda, K., E. Hamelmann, A. Joetham, L. D. Shultz, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186: 449-454.
38. Yamashita, Y., N. Charles, Y. Furumoto, S. Odom, T. Yamashita, A. M. Gilfillan, S. Constant, M. A. Bower, J. J. Ryan, and J. Rivera. 2007. Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses. J. Immunol. 179: 740-743.
39. Noguchi, J., E. Kuroda, and U. Yamashita. 2005. Strain difference of murine bone marrow-derived mast cell functions. J. Leukoc. Biol. 78: 605-611.
40. Humbles, A. A., C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1776-1779. (Pubitemid 39249645)
41. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. McGarry, K. R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776. (Pubitemid 39249644)
42. Mattes, J., M. Yang, S. Mahalingam, J. Kuehr, D. C. Webb, L. Simson, S. P. Hogan, A. Koskinen, A. N. McKenzie, L. A. Dent, et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195: 1433-1444.
43. Walsh, E. R., N. Sahu, J. Kearley, E. Benjamin, B. H. Kang, A. Humbles, and A. August. 2008. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J. Exp. Med. 205: 1285-1292.
44. Alcorn, J. F., K. Ckless, A. L. Brown, A. S. Guala, J. K. Kolls, M. E. Poynter, C. G. Irvin, A. van der Vliet, and Y. M. Janssen-Heininger. 2010. Strain-dependent activation of NF-kappaB in the airway epithelium and its role in allergic airway inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 298: L57-L66.
45. Kaiko, G. E., and P. S. Foster. 2011. New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma. Curr. Opin. Allergy Clin. Immunol. 11: 39-45.
46. Barrett, N. A., and K. F. Austen. 2009. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 31: 425-437.